Definitive Healthcare Corp. (NASDAQ:DH) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Officer Robert Musslewhite – Chief Executive Officer Jason Krantz – Founder and Executive Chairman Rick Booth – Chief Financial Officer Conference Call Participants Jared Haase – William Blair Matt Shea – Needham & Co. Craig Hettenbach – Morgan Stanley Joe Vruwink – Baird David Grossman – Stifel Allen Lutz – Bank of America Johnathan McCary – Raymond James Jonathan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

Business Overview - As of December 31, 2022, Definitive Healthcare had over 3,000 active paid subscriptions to its platform[19]. - Definitive Healthcare's total addressable market is estimated to exceed $10 billion, targeting over 100,000 companies[31]. - The platform utilizes thousands of data sources and billions of data points, enhanced by AI and machine learning algorithms, to provide comprehensive healthcare commercial intelligence[23]. Workforce and Culture - The company employs 974 individuals, with 30% working fully remote, and has a workforce distribution of 517 in sales and marketing, 361 in product development, and 96 in general and administrative roles[34]. - The company has implemented unlimited paid time off and expanded parental leave for U.S.-based employees in 2022[42]. - The management team has a strong track record of exceptional financial performance and building a positive workplace culture[27]. - The company has been recognized as a Top Place to Work by The Boston Globe for six consecutive years[35]. Financial Performance - As of December 31, 2022, the company had cash and cash equivalents of $146.9 million and short-term investments of $184.9 million[340]. - The total principal balance outstanding on the 2021 Term Loan was $266.4 million as of December 31, 2022[341]. - A hypothetical 1.0% increase or decrease in the interest rate associated with borrowings under the 2021 Credit Agreement would result in an approximately $2.7 million impact to interest expense on an annual basis[342]. - The company does not believe inflation has had a material effect on its business, financial condition, or results of operations[344]. Risk Management - The company manages credit risk by concentrating cash deposits and short-term investments with high-quality financial institutions[345]. Growth Strategy - Definitive Healthcare's go-to-market strategy generates over 10,000 inbound Marketing Qualified Leads (MQLs) annually[30]. - The company aims to drive growth through acquiring new customers, expanding existing relationships, and making selective strategic acquisitions[27]. Intellectual Property - Definitive Healthcare has not pursued any patents as of December 31, 2022, but protects its intellectual property through contracts and confidentiality agreements[46]. International Presence - The company has one foreign entity established in Sweden and one in India, with functional currencies being the Swedish Krona and the Indian Rupee, respectively[343].

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chairman Rick Booth - CFO Conference Call Participants David Grossman - Stifel Craig Hettenbach - Morgan Stanley Jacob Staffel - Goldman Sachs Matt Shea - Needham Ryan Shanahan - Canaccord Genuity Glen Santangelo - Jefferies Brian Peterson - Raymond James Anne Samuel - JPMorgan Allen Lutz - Bank of America Operator ...

Definitive Healthcare Corp. (NASDAQ:DH) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants David Samuels - Chief Legal Officer Robert Musslewhite - CEO Jason Krantz - Founder & Chairman Rick Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Joe Vruwink - Baird Saket Kalia - Barclays David Grossman - Stifel Maxi Ma - Deutsche Bank Jonathan Yong - Credit Suisse Matt Shea - Needham Johnathan McCary - Raymond James Operator Good morning, afternoon, evening, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Delaware 86-3988281 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No. ...

Definitive Healthcare Corp (NASDAQ:DH) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Samuels - Chief Legal Officer Robert Musslewhite - President, CEO & Director Jason Krantz - Founder & Executive Chairman Richard Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Maxi Ma - Deutsche Bank David Grossman - Stifel, Nicolaus & Company Jonathan Yong - Crédit Suisse Saket Kalia - Barclays Bank Ryan MacDonald - Needham & Company Operator Good day, and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other juri ...

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants David Samuels - General Counsel & Chief Legal Officer Jason Krantz - Founder and CEO Robert Musslewhite - President Richard Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley David Hynes - Canaccord Genuity Jonathan Yong - Credit Suisse David Grossman - Stifel Operator Greetings, and welcome to Definitive Healthcare First Quarter 2022 Earnings Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...